Θωμαΐς Κωνσταντοπούλου
Market Access Director Greece, Cyprus & Malta, Janssen Greece
A business and market access executive with over 20 years in the pharmaceutical industry and HCS/payer-side roles, Thomais Konstantopoulou gained valuable experience in various national and international capacities. With a professional background spanning Clinical Operations, Medical Affairs, Marketing, and Market Access, she has navigated diverse therapeutic disciplines and global settings, progressively assuming higher responsibilities.
Her leadership at Janssen Greece Market Access Unit oversees a dynamic portfolio encompassing Oncology, Hematology, Immunology, HIV, Neuroscience, and PAH, driving pricing and complex reimbursement activities. Guiding a team of 6 skilled associates, including HEMAR, Policy, RWE & Pricing experts, Thomais has transitioned back to Greece from leading Oncology Marketing team at Novartis Oncology in France.
Previously, serving as Global Access Lead for Breast Cancer, Thomais focused on optimizing pricing and reimbursement in China, LATAM, Emerging Markets and Taiwan. Her tenure as Oncology Access Director for Region Europe at Novartis enhanced her expertise in HTA-based HCS like the UK, Germany, France, Nordics, the Netherlands, as well as BI-driven markets like Spain, Italy, Eastern European countries, and Russia. She has supported diverse country teams in sophisticated oncology reimbursement submissions and pricing strategies.
She holds a BSc in Pharmacy from the University of Szeged, Hungary and an MSc in Health Economics, Policy and Management from the London School of Economics & Political Science (LSE), UK.